The FDA just approved the world’s first 3D-printed medication for people with epilepsy

PictureAprecia Pharmaceuticals announced today that the FDA has approved their SPRITAM drug, making this the world’s first 3D-printed medication.SPRITAM is a seizure medication developed using Aprecia’s ZipDose technology and helps people who suffer from epilepsy. The company’s 3D-printing technology allows the medication to become water soluble with minimal amounts of liquid, enabling the medication to be absorbed at a much faster rate. The video below shows how the medication can become water soluble and enter the bloodstream within seconds. 

Don Wetherhold, Chief Executive Officer of Aprecia says in a press release:
“By combining 3DP technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience.”

ZipDose Technology allows patients to take higher dosages, up to 1,000 mg in a single dose resulting in an enhanced patient experience. Additionally, SPRITAM requires no measurement since each dose is individually packaged, making it easy to carry the medication on the go. This is groundbreaking news for the pharmaceutical industry and for those who suffer from epilepsy. 

Aprecia expects SPRITAM is to be available in the first quarter of 2016.

The implementation of 3D-printing in the medical field is nothing new. Many companies are exploring ways that they can implement this technology. L’Oreal is one company who is using this technology to print human skin.

Suggested News Hubs To Visit On infoBlizzard:

More Articles From infoBlizzard’s Blog Smog:

RSS Feed Widget

Leave a comment

Your email address will not be published. Required fields are marked *